ArticleAnnals of hematology2021

Combined use of interferon alpha-1b, interleukin-2, and thalidomide to reverse the AML1-ETO fusion gene in acute myeloid leukemia.

Ruihua Mi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.